Creatine has been reported to exert beneficial effects in several neurodegenerative diseases in which glutamatergic excitotoxicity and oxidative stress play an etiological role. The purpose of this study was to investigate the protective effects of creatine, as compared to the N-Methyl-D-Aspartate (NMDA) receptor antagonist dizocilpine (MK-801), against glutamate or hydrogen peroxide (H 2 O 2 )-induced injury in human neuroblastoma SH-SY5Y cells. Exposure of cells to glutamate (60e80 mM) or H 2 O 2 (200e300 mM)
Introduction
Glutamate, the main excitatory neurotransmitter in mammalian brain (Platt, 2007) plays important roles in neuronal function such as plasticity and cognitive processes (Meldrum, 2000) . However, an enhanced glutamatergic neurotransmission has been reported to be implicated in the pathophysiology of neurological diseases such as Parkinson's disease, Alzheimer's disease, epilepsy, ischemic stroke, anxiety, and depression Siegel and Sanacora, 2012; Tzschentke, 2002) . Several in vitro experiments indicate that at high concentrations, glutamate acts as a neurotoxin, inducing excitotoxicity and, consequently, programmed cell death (Mattson, 2000) . Glutamate excitotoxicity has been linked to mitochondrial dysfunction with subsequently oxidative damage and reduction of intracellular ATP levels in several cell culture studies, including primary neurons, PC12 and neuroblastoma SH-SY5Y cells (Ankarcrona et al., 1995; Behl et al., 1995; Pereira and Oliveira, 2000; Schubert and Piasecki, 2001; Sun et al., 2010a) . Specifically, it has been demonstrated that glutamate produces elevation of malondialdehyde content, a lipoperoxidation indicative, glutathione depletion, as well as a decrease in superoxide dismutase activity (Ankarcrona et al., 1995; Behl et al., 1995; Pereira and Oliveira, 2000; Schubert and Piasecki, 2001; Sun et al., 2010b) . Furthermore, it has been reported that glutamate toxicity may be prevented by several antioxidants, reinforcing the idea that glutamate-induced cell damage is mediated by the increase in free radicals generation Oliveira, 1997, 2000) . In addition, hydrogen peroxide (H 2 O 2 ) was reported to be able to increase glutamate release, consistent with the fact that NMDA receptor (NMDAR) activation contributes to H 2 O 2 -induced neuronal apoptosis (Genius et al., 2012; Mailly et al., 1999) .
In response to activation of glutamate receptors (NMDA, AMPA or Kainate), voltage-gated Ca 2þ channels open and intracellular Ca 2þ concentration rises, activating nitric oxide synthase, responsible for nitric oxide (NO) synthesis from L-arginine conversion (Contestabile, 2000; Esplugues, 2002; Yamamoto et al., 2004) . NO is a free radical which in combination with superoxide anion forms the very reactive radical specie peroxynitrite. Many of the detrimental effects of NO have been attributed to peroxynitrite, because this molecule is able to nitrate and oxidize protein residues as well as catecholamines, DNA, and lipids, thereby affecting cellular homeostasis (Torreilles et al., 1999) . Since NMDAR antagonists can counteract glutamate excitotoxicity, they have been explored as therapeutic agents for various neurological conditions (Reisberg et al., 2003; Beister et al., 2004; Sulkowski et al., 2014) . However, therapeutical strategies for abrogating glutamate excitotoxicity have several limitations, mainly due to fact that pharmacological agents produce side effects (such as hallucinations, somnolence, perceptual disturbances, dissociation, euphoria, dysphoria, anxiety and seizures) and have a moderate efficacy in clinical studies (van Marum, 2009; Iadarola et al., 2015) . Thus, compounds capable of mimicking the effects of NMDAR antagonists, but without causing side effects, might represent new therapeutic targets in the treatment of glutamate excitotoxicity. In this context, a special attention has been given to nutraceutical compounds that may disrupt pathogenic pathways implicated in the development of neurological diseases, without causing significant side effects (Manosso et al., 2013; Swaminathan and Jicha, 2014) .
The guanidine-like compound creatine has been used for several decades as an ergogenic aid to improve exercise performance in humans (Cooper et al., 2012) . Of note, it has been proposed as a useful nutraceutical agent to ameliorate excitotoxicity-mediated diseases (Andres et al., 2008; Cunha et al., 2015; Persky and Brazeau, 2001; Wyss and Schulze, 2002) . For example, inborn or acquired diseases characterized by progressive loss of nervoussystem cells such as Alzheimer's, Huntington's, Charcot-MarieTooth's and Parkinson's disease and amyotrophic lateral sclerosis could be potentially treated by creatine administration (Gualano et al., 2012; Rae and Br€ oer, 2015) . Indeed, a growing number of reports have provided evidence for neuroprotective effects of creatine against glutamate-induced cell death (Brewer and Wallimann, 2000; Genius et al., 2012; Juravleva et al., 2005; Vielhaber et al., 2001) . Of note, creatine administration significantly attenuated striatal excitotoxic lesions produced by NMDA, but had no effect on lesions produced by AMPA or kainic acid (Malcon et al., 2000) . Furthermore, creatine directly inhibited NMDAR-mediated calcium response and ATP depletion induced by glutamate (Genius et al., 2012) . Moreover, creatine prevented the increase on NO levels induced by glutamate in neuron-glia cells (Juravleva et al., 2005) .
Some studies suggest that the benefits of creatine against rotenone, 6-OHDA, H 2 O 2 , staurosporine, tert-butylhydroperoxide and peroxynitrite may be attributed to its antioxidant properties (Cunha et al., 2014; Hosamani et al., 2010; Sartini et al., 2012; Sestili et al., 2006 Sestili et al., , 2011 . Moreover, Lawler et al. (2002) demonstrated that creatine acts directly as radical species scavenger, such as superoxide anions and peroxynitrite in acellular setting. However, it remains to be established if the antioxidant property of creatine contributes to its neuroprotective effect against glutamate-induced cell death. Therefore, this study aims to contribute on this issue by investigating the protective effect of creatine against glutamateinduced nitrosative and oxidative stress in human neuroblastoma SH-SY5Y cell line.
Materials and methods

Drugs and chemicals
Dulbecco's modified Eagle's medium: Nutrient mixture F-12 (DMEM/F12), Antibiotic-Antimycotic, Fetal Bovine Serum (FBS) purchased from GIBCO (Grand Island, NY, USA). Creatine monohydrate, glutamate, hydrogen peroxide (H 2 O 2 ), dimethylsulfoxide (DMSO), MTT, Griess reagent and tetramethylrhodamine ethylester (TMRE) were obtained from Sigma Chemical Co, USA. All other reagents were of analytical grade.
Glutamate was dissolved in Eagle's minimal essential medium (EMEM), at a final concentration of 8 M.
Animals
Female Swiss mice (30e40 g) were obtained from the Central Biothery of Universidade Federal de Santa Catarina (UFSC). They were housed in groups of fourteen animals per plastic cage (42 Â 24 Â 17 cm) under controlled conditions of light (from 07:00 to 19:00 h) and temperature (21 ± 1 C). Mice were allowed free access to standard laboratory food and tap water. Each experimental group consisted of 6 animals. Animals were randomly distributed into specified experimental groups. All manipulations were carried out between 10:00e17:00 h, with each animal used only once. All procedures in this study were performed in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals and approved by the Ethics Committee of the Institution. All efforts were made to minimize animals suffering and to reduce the number of animals used in the experiments.
SH-SY5Y cell culture
Human neuroblastoma SH-SY5Y cells were chosen because they have been widely used to investigate functions related to neurodegenerative and neuroadaptive processes, neurotoxicity and neuroprotection (Ballaz et al., 2013; Nciri et al., 2013; Petroni et al., 2013) . SH-SY5Y cells were gently donated by Dr. Marcelo Farina (Biochemistry Department of Universidade Federal de Santa Catarina, Florian opolis, Brazil). SH-SY5Y cells were maintained in a 1:1 mixture of F-12 Nutrient Mixture (Ham12) (SigmaeAldrich, Madrid, Spain) and EMEM supplemented with 15 nonessential amino acids, 1 mM sodium pyruvate, 10% heat-inactivated fetal bovine serum (FBS), 100 units/ml penicillin, and 100 mg/ml streptomycin. Cultures were seeded into flasks containing supplemented medium and maintained in a monolayer at 37 C in a humidified atmosphere of 5% CO 2 and 95% air. Stock cultures were passaged 1:3 twice weekly; i.e., one plate was divided (subcultured or split) into three plates. This procedure was performed twice a week. For assays, SH-SY5Y cells were sub-cultured at a seeding density of 4 Â 10 5 (24-well plates) or 2 Â 10 5 cells (96-well plates) per well. Cells were incubated with the drugs solubilized in F-12/ EMEM medium supplemented with 1% FBS. All incubations were performed when cells were grown to about 65% confluence; at the end of treatment, cells reached about 80e90% confluence. All cells in this study were used at passages between 4 and 20.
SH-SY5Y cell treatments
Firstly, cells were treated with F-12/EMEM alone (supplemented with 1% FBS) or F-12/EMEM (supplemented with 1% FBS) containing glutamate at concentrations ranging from 5 to 80 mM or H 2 O 2 at concentrations ranging from 25 to 300 mM. thylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) reduction, DCF fluorescence, and NOx levels were analyzed 24 h after glutamate or H 2 O 2 addition.
Additionally, to study the protective effect of creatine and MK-801 in this cell death induction protocol, SH-SY5Y cells were preincubated (24 h before glutamate or H 2 O 2 ) and co-incubated (24 h during glutamate or H 2 O 2 incubation) with creatine at concentrations ranging from 0.1 to 10 mM, or MK-801 (0.1e10 mM), diluted in F-12/EMEM medium supplemented with 1% FBS. MTT reduction, DCF fluorescence and NOx levels were analyzed 48 h after creatine or MK-801 addition.
Hippocampal slices
To evaluate the effect of creatine on ex vivo hippocampal cellular viability, creatine (100e300 mg/kg, po) or vehicle was administered to mice acutely or sub-chronically for 21 days (once a day) and 60 min later of last administration they were killed by decapitation. After that, forebrains were rapidly removed from the skull and placed into ice-cold Krebs bicarbonate buffer (KRB), containing (in mM): NaCl 122, KCl 3, CaCl 2 1.3, NaHCO 3 25, MgSO 4 1.2, KH 2 PO 4 0.4, D-glucose 10, pre-bubbled with 95% O 2 /5% CO 2 up to pH 7.4. The hippocampi were quickly dissected and sectioned into transverse slices of 400 mm thick using a tissue chopper (McIlwain Tissue Chopper, The Micle Laboratory Engineering Company). After the preincubation time (30 min in KRB), the medium was withdrawn and added glutamate (at concentration of 10 mM) or KRB for additional 1 h. Subsequently, the medium was replaced by a nutritive culture medium composed of 50% KRB, 50% Dulbecco's modified Eagle's medium (DMEM, Gibco), 20 mM HEPES and 100 mg/ml gentamicin, at 37 C in a CO 2 atmosphere (Molz et al., 2008 ) and slices were maintained for an additional 4 h period to evaluate cellular viability and mitochondrial membrane potential.
MTT measurement
Cellular viability was measured using the MTT reduction assay as described previously (Mosmann, 1983) . At the end of the experimental protocol, the incubation medium was removed and MTT solubilized in Krebs-HEPES solution (144 mM NaCl, 5.9 mM KCl, 1.2 mM MgCl 2 , 2 mM CaCl 2 , 10 mM HEPES, and 11 mM glucose; pH 7.3) was added to each well at a final concentration of 0.5 mg/ ml, followed by an incubation at 37 C for 2 h. Thereafter, insoluble formazan was solubilized with DMSO and colorimetric determination of MTT reduction was measured at l 540 nm. Control cells treated with vehicle (DMEM/F12) were taken as 100% of cellular viability.
DCF fluorescence production
To measure cellular ROS, H 2 DCFDA probe was used (LeBel et al., 1992) . H 2 DCFDA diffuses through the cell membrane and is cleaved by intracellular esterases to the non-fluorescent form dichlorofluorescein (H 2 DCF). H 2 DCF reacts with intracellular reactive oxidants to form dichlorofluorescein (DCF), a green-fluorescent dye. SH-SY5Y cells medium was changed to HBSS buffer (136 mM NaCl, 5.4 mM KCl, 1.4 mM MgCl 2 , 1 mM NaH 2 PO 4 , 1.2 mM CaCl 2 , 10 mM HEPES, 9 mM Glucose) containing the probe H 2 DCFDA (10 mM) and incubated for 0.5 h at 37 C. At the end of incubation, the HBSS buffer containing H 2 DCFDA was changed by HBSS buffer alone and the fluorescence was measured in a plate reader (Spectra Max GEMINI XPS, Molecular Devices, USA) with an excitation wave length of 485 nm and emission of 520 nm (Parada et al., 2010; Quincozes-Santos et al., 2013) . The DCF fluorescence production was calculated as Unit of Fluorescence of DCF e UF/mg protein and was expressed as percentage of control.
Analysis of mitochondrial membrane potential
To analyze the mitochondrial membrane potential (Jm) the fluorescent probe TMRE was used. TMRE is a cationic lipophilic dye that is accumulated in the mitochondrial matrix in active mitochondria when it is negatively charged (Ehrenberg et al., 1988) . At the end of protocol, hippocampal slices were incubated with TMRE (100 nM) in KRB for 30 min at 37 C. Then, the hippocampal slices were removed from the medium containing TMRE and transferred to a 96-well plate. Then, slices were incubated individually with KRB buffer (200 mL/well) and the fluorescence was measured using a plate reader (Labsystems iEMS Reader MF) at the wavelengths of 550 and 590 nm for excitation/emission, respectively (Lorrio et al., 2013) .
Nitric oxide production
NO production was inferred by measuring nitrite, a stable oxidation product of NO, based on the Griess reaction. The Griess reagent was prepared by mixing equal volumes of 1% sulfanilamide in 0.5 M HCl and 0.1% N-(1-naphthyl) ethylenediamine in deionized water. The assay was performed as described by Hu et al. (1996) and adapted by Quincozes-Santos et al. (2013) . Briefly, cells were cultured on 24-well plate and after treatment, the Griess reagent was added directly to the cell culture and the incubation was maintained under reduced light at room temperature during 15 min. Samples were analyzed at 550 nm on a microplate spectrophotometer. Nitrite concentrations were calculated using a standard curve prepared with sodium nitrite (0e50 mM).
Caspase 3 activity
Caspase 3 activity was determined using colorimetric assay kit (SigmaeAldrich, CASP3C Sigma). Caspase 3 activity was determined using acetyl-Asp-Glu-Val-Asp p-nitroanilide (Ac-DEVDpNA), a preferred substrate for caspase-3. The hydrolysis of Ac-DEVD-pNA by caspase 3 produces the p-nitroaniline (pNA) release. The enzyme-catalyzed release of pNA was monitored at 405 nm in an ultraviolet microplate reader.
2.11. NO production from sodium nitroprusside: assay of nitrite production Sodium nitroprusside (5 mM, in phosphate-buffered saline) was incubated at 25 C with different concentrations of creatine (1e100 mM). After 120 min, 0.5 mL of incubation solution was sampled and mixed with 0.5 mL of Griess reagent (0.1% N-(naphthyl) ethylenediamine dihydrochloride and 1% sulfanilic acid in 5% phosphoric acid). The absorbance was measured at 550 nm. The amount of nitrite was calculated using a standard curve with different concentrations of sodium nitrite. A curve of sodium nitrite carried out in the presence of the creatine showed no creatine interference in the color development after Griess reagent addition. The values were compared with the control to determine the percentage of the nitrite reaction inhibition using a colorimetric reaction with Griess reagent (Colle et al., 2012a (Colle et al., , 2012b Marcocci et al., 1994) .
Protein determination
Protein content was measured by Lowry's method using bovine serum albumin as standard (Lowry et al., 1951) .
Statistical analysis
Data are given as means þ SEM. Differences between groups were determined by a one-way ANOVA followed by a NewmaneKeuls test when appropriate. Differences were considered statistically significant when p < 0.05.
Results
Effects of creatine or MK-801 on cellular viability of SH-SY5Y cells
Creatine or MK-801, at concentrations of 0.1e10 mM and 0.1e1000 mM, respectively, were incubated in human neuroblastoma SH-SY5Y cells. No effect of creatine on cellular viability assessed by MTT assay was observed under these concentration ranges (data no shown). MK-801 incubated, at high concentration (100e1000 mM), decreased the SH-SY5Y cellular viability (data no shown).
Effects of creatine or MK-801 on the glutamate-induced reduction on cellular viability in human neuroblastoma SH-SY5Y cells
Glutamate exposure was used to induce decreased neuroblastoma cellular viability, since it plays a pivotal role in the pathophysiology of neurodegenerative and psychiatric diseases (Dong et al., 2009; Sanacora et al., 2012) . Fig. 1A depicts the cytotoxic concentration-dependent effects of glutamate incubation in SH-SY5Y cells. To study the protective effect of creatine or MK-801, 80 mM of glutamate was chosen, because this concentration decreased cellular viability to values near to 50% of control. We tested the cytoprotective effect of creatine and MK-801 at doses of 0.1e10 mM and 0.1e10 mM, respectively. Creatine (1 and 10 mM) and MK-801 (0.1, 1 and 10 mM) significantly protected human neuroblastoma cells against glutamate cytotoxicity (Fig. 1B and C , respectively).
3.3. Effects of creatine or MK-801 on H 2 O 2 -induced reduction on cellular viability in human neuroblastoma SH-SY5Y cells H 2 O 2 exposure was used to induce reduced cellular viability because neural cell death associated with pro-oxidative events has been reported to exert a key role in the pathophysiology of neurodegenerative and psychiatry conditions (Behl et al., 1994) . Fig. 2A shows that H 2 O 2 caused a concentration-dependent cytotoxic effect. To study the protective effect of creatine or MK-801, the dose of 300 mM H 2 O 2 , which caused decreased cellular viability to values near to 43% of control, was chosen. Creatine (10 mM) and MK-801 (0.1, 1 and 10 mM) significantly protected human neuroblastoma cells against H 2 O 2 cytotoxicity (Fig. 2B and C,  respectively) .
The effect of creatine on the caspase 3 activity in the SH-SY5Y cells
We investigated the effect of creatine on the caspase 3 activity, an apoptosis indicative. Creatine (10 mM) was able to prevent the increase of caspase 3 activity induced by H 2 O 2 (300 mM) or glutamate (80 mM), indicating an antiapoptotic effect of creatine (Fig. 3) . Furthermore, creatine incubation per se decreased caspase 3 activity ( Fig. 3A and B) .
Ability of creatine or MK-801 to prevent the DCFH oxidation
Take into account that an imbalance between production and removal of ROS toward the pro-oxidative state can be promoted by the cellular exposure to H 2 O 2 , we investigated the effect of creatine and MK-801 on the DCF fluorescence, an indicative of intracellular ROS production. Either creatine (10 mM) or MK-801 (0.1 mM) was able to prevent the increase of H 2 DCF oxidation induced by H 2 O 2 (300 mM) or glutamate (80 mM) after 24 h of exposure to insult, indicating an antioxidant effect of creatine and MK-801 (Fig. 4) .
3.6. Glutamate-or H 2 O 2 -induced nitric oxide production was prevented by creatine or MK-801
The production of NO was indirectly measured by the formation of nitrite, expressed in mM. The results depicted in Fig. 5A and B shows that glutamate at doses of 60e80 mM and H 2 O 2 at dose of 300 mM increased NOx levels (11.9 ± 0.10 to 34.70 ± 5.12 and 33.45 ± 5.28 mM and 10.69 ± 0.17 to 18.72 ± 1.9 mM, respectively).
Glutamate (80 mM) increased nitrite formation and this effect was completely prevented by creatine and MK-801 ( Fig. 5D and F, respectively). Furthermore, H 2 O 2 (300 mM) increased nitrite formation and this effect was also completely blocked by either creatine or MK-801 ( Fig. 5C and E, respectively).
Effects of creatine on nitrite production from solution of sodium nitroprusside
When sodium nitroprusside (5 mM) was incubated at 25 C for 120 min, it generated a linear time-dependent nitrite production of about 5 ± 0.2 mM/h which was decreased by the presence of creatine (10e100 mM) in cell free experiments ( Fig. 6 ; P < 0.05).
Effect of creatine treatment in mice on the cellular viability and TMRE fluorescence of hippocampal slices exposed to glutamate
To validate the in vitro neuroprotective effect of creatine in SH-SY-5Y, mice were administered with creatine (100e300 mg/kg, po) or vehicle (distilled water) acutely or repeatedly for 21 days and hippocampus was sliced and incubated with KRB or glutamate (10 mM). Acute treatment of mice with creatine did not prevent the glutamate-induced reduction on cellular viability (Fig. 7A ) and on mitochondrial membrane potential (Fig. 7C) . However, the repeated treatment with creatine (300 mg/kg, po) for 21 days blocked the glutamate-induced reduction on cellular viability (Fig. 7B ) and on mitochondrial membrane potential (Fig. 7D) .
Discussion
The main finding of this study is that creatine, a guanidine-like compound, can afford protection in an experimental model of glutamate-induced toxicity by a mechanism that implicates oxidative and nitrosative stress modulation, similar to the positive control MK-801.
Glutamate, the major excitatory amino acid in the central nervous system of mammals, is involved in important brain functions, such as memory and learning (Meldrum, 2000) . However high glutamate concentrations in the synaptic cleft may be implicated in the pathophysiology of neurodegenerative and psychiatric diseases, such as Alzheimer's disease (Doble, 1999; Hynd et al., 2004 ), Parkinson's disease (Blandini et al., 1996a (Blandini et al., , 1996b , and major depression contributing to the observed neuronal degeneration (Cacabelos et al., 1999; Sonsalla et al., 1998) . In the present study, glutamate decreased the cellular viability of human neuroblastoma SH-SY5Y cells. These results are in agreement with literature data that shows that glutamate reduces cellular viability in differentiated and undifferentiated SH-SY5Y human neuroblastoma cells (Ballaz et al., 2013; Hu et al., 2012; Nciri et al., 2013; Petroni et al., 2013; Sun et al., 2010b; Xu et al., 2012) . The millimolar concentrations of glutamate necessary to produce the reduction on cellular viability are in agreement with other studies carried out in undifferentiated SH-SY5Y cells (Hu et al., 2014; Taveira et al., 2014; Tian et al., 2014) . Glutamate excitoxicity may involve mitochondrial dysfunction with subsequently reduction of intracellular ATP levels and oxidative damage (Ankarcrona et al., 1995; Sun et al., 2010b) . Interestingly, in the present study glutamate increased ROS in SH-SY5Y cells at levels similar to those obtained in presence of H 2 O 2 . In line with this, recent studies also demonstrated an increased ROS production in SH-SY5Y exposed to glutamate (Taveira et al., 2014; Xu et al., 2012) . Interestingly, ascorbate, a well-known antioxidant agent, was able to prevent glutamate-induced oxidative stress and cell death in SH-SY5Y cells (Ballaz et al., 2013) .
Once NMDAR are activated, intracellular calcium levels increase, leading to NO synthesis by NOS (Esplugues, 2002) . NO, first identified as endothelium-derived relaxing factor, is produced in different cell types of multicellular organisms where it acts as a diffusible messenger in many forms of intercellular communication as well as intracellular signaling (Bredt and Snyder, 1992; Contestabile, 2000; Contestabile et al., 2003; Kerwin et al., 1995; Moncada et al., 1989; Nathan, 1992) . Nevertheless, large amounts of NO are neurotoxic leading to neuronal cell death (Baranano et al., 2001; Calabrese et al., 2007; Cheng et al., 2003; Meldrum and Garthwaite, 1990) . The exposure of neuronal cells to NO donors induced apoptotic cell death and ROS production, while pretreatment with free radical scavengers attenuated these effects (Wei et al., 2000) . Conversely, studies show that H 2 O 2 induces NO production in mesophyll cells of maize leaves and C6 astrocyte cell line, and the pretreatment with antioxidants, NO scavenger and NOS inhibitor substantially reduced the H 2 O 2 -induced production of NO (Zhang et al., 2007; Quincozes-Santos et al., 2013) . In the present study, similar to H 2 O 2 , glutamate increased NOx levels in SH-SY5Y cells, suggesting that NO production induced by glutamate could be associated with oxidative stress. Corroborating this result, a study demonstrated that neuronal/glial cells incubated with glutamate increased NO levels production (Juravleva et al., 2003 (Juravleva et al., , 2005 .
Creatine exerts bioenergetic, antiexcitotoxic, antioxidant and neuroprotective properties. In the present study, creatine exerted neuroprotective effect against glutamate and H 2 O 2 toxicity in SH-SY5Y cells. Interestingly, the creatine level in the human brain is approximately 10 mM (Lin et al., 2006) and in the present study creatine at concentration of 1e10 mM produces protective effect against glutamate or H 2 O 2 toxicity. We suggest that the glutamate excitotoxicity and oxidative stress could reduce the transport rate of creatine into the cytosol. Since creatine transporter works at half maximal rate under physiological conditions (Guerrero-Ontiveros and Wallimann, 1998), the reduced transportation rate of creatine may be compensated by an elevated concentration of creatine in the incubation medium. It was demonstrated that hippocampal slices incubated with creatine at concentration 3 mM presented an enhancement on creatine and phosphocreatine levels. Creatine was also able to prevent the decrease in the concentrations of creatine and phosphocreatine induced by anoxia, an excitotoxic stimulus (Carter et al., 1995) . In addition, a study demonstrated that the H 2 O 2-induced oxidative condition decreased the intracellular creatine and phosphocreatine contents and this effect was abrogated by creatine co-incubation ). These findings suggest that both oxidative stress and excitotoxicity are able to modulate the energetic metabolism, particularly creatine kinase/ phosphocreatine system. Corroborating with our study, the protective potential of creatine has been extensively assessed in various models of toxicity, including in vitro studies (Cunha et al., , 2014 (Cunha et al., , 2015 Fimognari et al., 2009; Sartini et al., 2012; Sestili et al., 2009 Sestili et al., , 2006 Young et al., 2010 ) and animal models (Deminice et al., 2009; Hosamani et al., 2010; Matthews et al., 1999; Rambo et al., 2009; Royes et al., 2006; Saraiva et al., 2012; Sullivan et al., 2000) of oxidative stress. Furthermore, studies with creatine supplementation in humans have demonstrated that this compound exhibits antioxidant effects (Coco and Perciavalle, 2012; Deminice et al., 2013; Kingsley et al., 2009; Rahimi, 2011) . To investigate that creatine prevented the increase on the DCF fluorescence as compared to group incubated with glutamate or H 2 O 2 alone (Panels B and C, respectively). Data are shown as mean þ SEM of eight different and independent cell batches. ** P < 0.01 or *** P < 0.001 with respect to control; # P < 0.05 or ### P < 0.001 as compared to 80 mM glutamate group or 300 mM H 2 O 2 group, respectively. neuroprotection actually relies on its antioxidant activity, we hypothesized that creatine could protect cells against the reduction on cellular viability induced by the pro-oxidant agent H 2 O 2 . For this purpose we used the human neuroblastoma SH-SY5Y cells that when incubated with H 2 O 2 has its cellular viability decreased in parallel with accumulation of ROS . In the present study pre and co-incubation with creatine elicited protective effects against H 2 O 2 -induced SH-SY5Y cell death and oxidative stress. Creatine has been shown to promote other relevant effects which contribute to rescue cellular viability and function under oxidative stressing. For example creatine i) preserves the integrity of mitochondria allowing adequate mitochondriogenesis, probably via its organelle-directed antioxidant activity (Guidi et al., 2008) ; ii) affords a significant sparing of intracellular thiols content; iii) protects RNA from oxidative damage in a condition requiring a robust mRNA utilization dependent on its capacity to directly scavenge free radicals (Fimognari et al., 2009) ; and (iv) protects cells from oxidative insult induced by 6-OHDA, independent of an antioxidant direct action on 6-OHDA (Cunha et al., 2014) . The neuroprotective effect of creatine on glutamate-induced excitoxicity is well established in several cell cultures, as neuronal/glial, primary rat embryonal hippocampal neurons and cortical neurons cells (Brewer and Wallimann, 2000; Cunha et al., 2015; Genius et al., 2012; Juravleva et al., 2003 Juravleva et al., , 2005 and in animal models (Malcon et al., 2000; Mikati et al., 2004) , although studies addressing the direct relationship of neuroprotective effect of creatine against glutamate-induced toxicity with its antioxidant properties are scarce. Since creatine was able to counteract the H 2 O 2 -induced increase in glutamate levels in hippocampal neurons with F-12/EMEM alone (0 mM of glutamate or H 2 O 2 ) or F-12/EMEM containing glutamate (60e80 mM) or H 2 O 2 (100e300 mM). Nitrite levels (Panels A and B, respectively) was analyzed 24 h after glutamate or H 2 O 2 addition. Pre-incubation (24 h before 80 mM glutamate or 300 mM H 2 O 2 ) and co-incubation (24 h during 80 mM glutamate or 300 mM H 2 O 2 incubation) of SH-SY5Y cells with creatine (10 mM) or with NMDAR antagonist MK-801 (0.1 mM) decreased nitrite levels as compared to group incubated with glutamate or H 2 O 2 alone (Panels C, D, E and F, respectively). Nitrite production was measured as described in the experimental procedures section. Data are shown as mean þ SEM of eight different and independent cell batches.
* P < 0.05 or ** P < 0.01 or *** P < 0.001 with respect to control; # P < 0.05 or ## P < 0.01 as compared to 80 mM glutamate group. ( Genius et al., 2012) , we hypothesized that creatine could have neuroprotective effect against glutamatergic excitotoxicity via oxidative stress modulation. In the present study, creatine prevented the reduction of cellular viability and the increase of DCF fluorescence in SH-SY5Y cells challenged with glutamate or H 2 O 2 (positive control). Conversely, a study demonstrated that creatine increased the superoxide radical signal in electron paramagnetic resonance spectroscopy analysis, while the combination of creatine and glutamate resulted in greater signal intensity than cells treated with creatine or glutamate alone (Juravleva et al., 2005) . This difference could be due to distinct cell line, protocol and time point used in the previous study to analyze ROS production. Furthermore, a limitation of our study is that DCFH dye does not directly react with superoxide, hydrogen peroxide, or nitric oxide (Kalyanaraman et al., 2012) . Instead, DCF fluorescence results from oxidation by potent oxidants, such those produced from metal ions, peroxidasecatalyzed reactions and protons-and carbons dioxide-catalyzed decomposition of peroxynitrite (Forman et al., 2015) . Similar to creatine, the selective serotonin reuptake inhibitor fluoxetine produces antidepressant effect in animal models and produces neuroprotective effect against glutamate or H 2 O 2 in neuroblastoma SH-SY5Y cells (Cunha et al., 2012; Hu et al., 2014) , suggesting that compounds with antidepressant properties may also present neuroprotective effects against glutamate-induced oxidative injury. Of note, a recent study from our group demonstrated that the antidepressant property of creatine is dependent on NMDAR modulation (Cunha et al., 2015) .
Our results are in line with the findings that creatine presents a direct inhibitory action on NMDAR-mediated calcium response (Genius et al., 2012) . Interestingly, creatine, at dose of 10 mM, but not 1 mM, has a depressing action on neuronal excitation in hippocampal slices subjected to anoxia and control hippocampal slices (Parodi et al., 2003) . Conversely, creatine at a dose of 1 mM increased the binding of [
3 H]MK-801 in hippocampal membrane of rats, further supporting a functional modulatory role on NMDAR activation for this guanidine-like compound at low doses (Royes et al., 2008) . Reinforcing the notion that NMDAR antagonism exhibits neuroprotection in neuroblastoma SH-SY5Y cells, our results also suggests that creatine shares with the NMDAR antagonist MK-801 similar mechanisms regarding modulation of glutamate-and H 2 O 2 -induced oxidative stress, indicating that NMDAR antagonism may present anti-excitotoxicity effect in oxidative stress conditions, leading to cell survival. Literature data show that MK-801 produces anti-excitotoxicity properties against distinct agents, as HIV-TAT, hydrogen sulfide, glutamate or NMDA, in neuroblastoma SH-SY5Y cells (Capone et al., 2013; Petroni et al., 2013; Sun and Murali, 1998; Young et al., 2010; Zhu et al., 2009) . Reinforcing this notion, a study also demonstrated that the neuroprotective effect of MK-801 against HIV-TAT is dependent on its antioxidant activity, since pretreatment of SH-SY5Y cells with MK-801 was able to completely inhibit the increase of DCF fluorescence and to restore cellular viability (Capone et al., 2013) . Furthermore, another possibility that may explain our results is that NMDAR antagonists such as MK-801 and ketamine could decrease the noradrenaline uptake in SH-SY5Y cells (Neukirchen et al., 2012) and this may be an important event for their neuroprotective effects in such cells.
In the present study, creatine, as well as MK-801, blocked the enhancement of glutamate-and H 2 O 2 -induced NOx levels in SH-SY5Y cells. This result is in agreement with a study which demonstrated that creatine supplementation resulted in complete restoration of NO to normal levels in Drosophila melanogaster treated with rotenone (Hosamani et al., 2010) . In line with this, creatine has been reported to be able to abolish the increases of NO levels induced by glutamate in the neuronal/glial cells (Juravleva et al., 2003 (Juravleva et al., , 2005 .
NO is a very unstable specie, under aerobic conditions it reacts with oxygen to produce, through intermediates such as nitrogen Fig. 7 . Chronic creatine administration in mice produces neuroprotective effects against glutamate-induced toxicity in the hippocampus. Acute treatment of mice with creatine (100e300 mg/kg, po) did not prevent the glutamate-induced reduction on hippocampal cellular viability (Fig. 7A ) and on mitochondrial membrane potential (Fig. 7C) . However, the repeated treatment with creatine for 21 days blocked the glutamate-induced reduction on hippocampal cellular viability (Fig. 7B ) and on mitochondrial membrane potential (Fig. 7D) . Data are shown as mean þ SEM of six animals. * P < 0.05 or ** P < 0.01 or *** P < 0.001 with respect to control; # P < 0.05 as compared to 10 mM glutamate group.
dioxide, dinitrogen trioxide, dinitrogen tetroxide, the stable products nitrate and nitrite (Murphy and Sies, 1991; Stamler et al., 1992) . In the present study, when NO was produced from sodium nitroprusside in cell free experiments, creatine was able to inhibit the accumulation of nitrite generated during the reaction of NO with oxygen. Interestingly, NO scavengers, as well as other nitrogen oxide intermediates in the chemistry reaction that generate nitrite and nitrate from NO and oxygen, affect the accumulation of nitrite (Marcocci et al., 1994) . Thus, the effect of creatine on nitrite levels may be a consequence of the reaction of the creatine with the other nitrogen oxides, as nitrogen dioxide, dinitrogen trioxide, dinitrogen tetroxide and peroxynitrite, which are highly reactive. Also, peroxynitrite is formed in a near diffusion-controlled reaction between NO and superoxide anion and is a reactive species capable of inducing oxidative stress more pronounced than other reactive species (DiGuiseppi and Fridovich, 1984; Fridovich, 1983) . Interestingly, in cell-free environment employing xanthine oxidase/ xanthine system, an enzymatic generator of superoxide anions, creatine added in concentrations up to 5 mM did not reveal any antioxidant property (Genius et al., 2012) . However, the present data clearly demonstrated that creatine was able to reduce nitrite formation, suggesting that a scavenger activity of creatine against reactive nitrogen species may account for its neuroprotective property against glutamate or H 2 O 2 -mediated toxicity. Reinforcing this notion, creatine showed ability to scavenger peroxynitrite in acellular assay (Lawler et al., 2002) . Interestingly, creatine, at same concentration used in the present study (10 mM) significantly protected U937 cells from the peroxynitrite and H 2 O 2 -mediated toxicity (Sestili et al., 2006) . In addition, we validated the in vitro neuroprotective effect of creatine against glutamate toxicity by testing the ability of creatine administered in vivo to mice to counteract glutamate-mediated toxicity in hippocampal slices. Mice administered with creatine (300 mg/kg, po) for 21 days, but not acutely, presented an enhancement on glutamate-induced reduction in hippocampal cellular viability and mitochondrial membrane potential. Interestingly, a study demonstrated that acute creatine administration (300 mg/kg, po) in rats increased the total creatine (creatine þ phosphoreatine) content, creatine kinase activity and the mitochondrial membrane potential (DJ) in the cerebral cortex and prevented pentilenotetrazol-induced mitochondrial dysfunction characterized by decreasing DJ, increasing thiobarbituric acid-reactive substance levels and increasing protein carbonylation (Rambo et al., 2013) . Furthermore, we previously demonstrated that creatine is able to prevent the mitochondrial dysfunction and reduction in cellular viability induced by dopaminergic toxin 6-OHDA (Cunha et al., 2014) .
Collectively, the results presented herein demonstrate that creatine exerts protective action against oxidative and nitrosative stress induced by glutamate, reinforcing the notion that creatine may be a therapeutic agent for the management of a number of neurologic diseases associated with excitotoxicity/oxidative stress. 
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